About the Principal Investigator
Dr. Murphy began his research career in the laboratory of Andrew D. Leavitt in the Department of Laboratory Medicine at the University of San Francisco where he was responsible for research projects designed to identify the genes involved in megakaryocyte development. He received his Ph.D from Oxford University while working in the laboratory of Jonathan Frampton where he investigated the role of Ets transcription factors in hematopoietic cell development using targeted retroviral infection and gene transfer models. Dr. Murphy conducted his postdoctoral studies as a fellow in molecular medicine and genetics at Harvard Medical School and the Boston Children’s Hospital in the laboratory of Richard Mulligan, Ph.D. Dr. Murphy has recently been recruited to the faculty of the Section of Hematology and Oncology in the Department of Medicine at Boston University and the Boston Medical Center. His main research interests are hematopoiesis, megakaryocyte development, stem cell biology, and gene and cell-based therapies.